Related Experiment Video
Updated: Jul 28, 2026
09:11
Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
Therapeutic options in advanced heart failure
M L Fisher1, C W Balke, R Freudenberger
1Division of Cardiology, Department of Medicine, University of Maryland School of Medicine, Baltimore, USA.
Hospital Practice (1995)
|June 28, 2003
Summary
Advanced heart failure treatment is challenging but potentially reversible. Beta-blockers show promise for severe cases, with transplantation and new therapies offering future alternatives.
Area of Science:
- Cardiology
- Heart Failure Research
Background:
- Advanced heart failure presents significant treatment challenges.
- Beta-blocker efficacy in mild to moderate heart failure suggests potential reversibility in severe cases.
- Current definitive treatment is heart transplantation.
Purpose of the Study:
- To explore the potential reversibility of severe heart failure.
- To review alternative treatment strategies beyond transplantation.
Main Methods:
- Review of existing literature on heart failure treatments.
- Analysis of beta-blocker effectiveness in cardiac dysfunction.
- Evaluation of emerging medical, mechanical, and surgical options.
Main Results:
- Beta-blockers successfully manage mild to moderate heart failure symptoms.
- Evidence suggests severe heart failure may be reversible.
- Transplantation is the only current method for a fully functional heart.
Conclusions:
- Severe heart failure may be reversible, challenging traditional views.
- New medications, mechanical devices, and surgical procedures are emerging as potential alternatives to transplantation.
- Further research into these novel therapies is warranted for advanced heart failure management.
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...